WEEXA BIOLOGICALS

Neupré ·KBO/BCE: BE 0791.956.795

Loading dossier…

Metric	This company	Sector median	Position in the sector
Solvency	62.5%	3.8%	better than 78% of 52 sector peers
Net result	€49k	€-6k	better than 91% of 52 sector peers
Equity	€121k	€2k	better than 90% of 52 sector peers
Gross operating margin	€65k	€-2k	better than 90% of 52 sector peers
Total assets	€193k	€87k	better than 71% of 52 sector peers

Line item	Code	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€193k
Fixed assets	21/28	€56k
Intangible fixed assets	21	€53k
Tangible fixed assets	22/27	€3k
Current assets	29/58	€137k
Stocks & contracts in progress	3	€13k
Amounts receivable within one year	40/41	€28k
Cash & bank	54/58	€96k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€193k
Equity	10/15	€121k
Contributions / capital	10/11	€10k
Reserves	13	€69k
Amounts payable	17/49	€72k
Amounts payable within one year	42/48	€48k
Trade debts payable within one year	44	€36k
Income statement
Gross operating margin	9900	€65k
Operating result	9901	€59k
Financial income	75	€2k
Financial charges	65	€309
Result before taxes	9903	€61k
Income taxes	67/77	€12k
Net result for the period	9904	€49k
Result to be appropriated	9905	€49k

Summary

Legal nameFR	WEEXA BIOLOGICALS
AbbreviationFR	WEEXA